TransMedics Group (TMDX)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

A(z) TransMedics Group, Inc. Common Stock (TMDX) részvény mai árfolyama , ami NaN% elmozdulást tükröz a piac nyitása óta. A vállalat piaci kapitalizációja jelenleg 4,84 Mrd $, a napi kereskedési volumen pedig  részvény. A korábbi záró ár volt.

Készen állsz? Kövesd az alábbi lépéseket, vagy olvasd el útmutatónkat a(z) hogyan vásárolj TransMedics Group részvényt a Krakenen, kezdve 10 dollárral.